Lixte terminates at-the-market equity facility with WallachBeth Capital; effective March 18, 2025

LIXTE BIOTECHNOLOGY HOLDINGS, INC.

Notice of termination of Sales Agreement with WallachBeth Capital LLC given on March 7, 2025.
Termination becomes effective ten days after notice, i.e., March 18, 2025.
Company plans to explore alternatives to raise additional equity capital.

item 1.01

LIXTE BIOTECHNOLOGY HOLDINGS, INC. filing history →

Source: SEC EDGAR

accession 0001493152-25-009786

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.